Adjuvant TKI therapy in resected EGFR-mutant non-small-cell lung cancer—ready for prime time?

Παρόμοια τεκμήρια

• Adjuvant treatment with EGFR TKI in resected non-small cell lung cancer with EGFR mutation: all that glitters is not gold!
  ανά: Fiorelli, Alfonso, κ.ά.
  Έκδοση: (2020)
• Adjuvant EGFR TKI therapy for resectable non-small cell lung cancer: new era for personalized medicine
  ανά: Shen, Peng, κ.ά.
  Έκδοση: (2018)
• Adjuvant TKI treatment of EGFR-mutant lung cancer—already ripe for decision?
  ανά: Kauffmann-Guerrero, Diego
  Έκδοση: (2020)
• EGFR-TKI-based vs non-EGFR-TKI-based adjuvant therapy in resected non-small-cell lung cancer with EGFR mutations: a meta-analysis of randomized controlled trials
  ανά: Wu, Jing-Xun, κ.ά.
  Έκδοση: (2018)
• Is It Time to Implement Adjuvant Targeted Therapy in EGFR-Mutant Non–Small-Cell Lung Cancer?
  ανά: Kulkarni, Amit A., κ.ά.
  Έκδοση: (2021)